|
Comment
An
Onlooker's Notebook
Leading
Article
In the driving seat...
Broad Spectrum
Learning
from nurse prescribing...
»(PDF*,
25K)
We
cannot afford cost before quality...
»(PDF*,
20K)
Letters
to the Editor
News
News
News
Feature
Collaborative medicines management...
»(PDF*,
15K)
Clinical
Pharmacy
Business
The Society
Statutory Committee
Committee proceedings
News
Obituaries
Articles
Ziprasidone — an atypical antipsychotic
»(PDF*,
110K)
Last bastion of free speech?
»(PDF*,
275K)
Pitfalls in business
»(PDF*,
275K)
Products
* PDFs require Acrobat Reader 4 or later. Click here
for the latest version
|
Front Cover Picture
Our front cover picture relates to our report about
the national collaborative programme on medicines management. This week
we consider what pharmacists can do to become involved (p378).
Comment (p375).
First CPP faculty
The College of Pharmacy Practice has launched its first faculty —
the faculty of prescribing and medicines management (p377).
Foot and mouth disease
Is emergency vaccination the answer? This week we carry an update for
pharmacists on the current foot and mouth disease outbreak (p379).
Cardiology
We carry several reports from the annual conference of the American College
of Cardiology which took place in Florida last week (p382).
Ziprasidone
Ziprasidone, a new atypical antipsychotic drug not yet licensed in the
United Kingdom, is reviewed on pp396–401.
Private-Rx
Is Private-Rx the last bastion of free speech or is it a thorn in the
side of the establishment? The Journal investigates (p402).
|
